Trial intelligence / Profile preview

Acthar in Psoriatic Arthritis (CLIPS)

NCT03419650Phase 4Completed

Sponsor
IRIS Research and Development
Start
Jul 2018
Primary completion
Aug 2021
Modality
Peptides
Countries
1
01

Overview

A Phase 4 trial of corticotropin in psoriatic arthritis (PsA), sponsored by IRIS Research and Development. Started Jul 2018; status: completed.

02

Drugs

corticotropin
03

Conditions

psoriatic arthritis (PsA)

Beyond the preview

Go deeper on NCT03419650.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03419650.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call